Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical operating margin
Operating margin is operating income as a percentage of revenue.
Escalon Medical's operating margin for the twelve months ending Jun 30, 2026 was 0.4%. For fiscal 2026 it was 0.4%, against 1.1% the year before. The highest annual figure on record is 3.9% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 0.4% | −0.8 |
| FY2025 | Jun 30, 2025 | 1.1% | +2.0 |
| FY2024 | Jun 30, 2024 | -0.9% | −4.8 |
| FY2023 | Jun 30, 2023 | 3.9% | +8.3 |
| FY2022 | Jun 30, 2022 | -4.4% | −4.1 |
| FY2021 | Jun 30, 2021 | -0.3% | +14.6 |
| FY2020 | Jun 30, 2020 | -14.9% | −12.3 |
| FY2019 | Jun 30, 2019 | -2.6% | −4.4 |
| FY2018 | Jun 30, 2018 | 1.8% | +7.4 |
| FY2017 | Jun 30, 2017 | -5.6% | +4.3 |
| FY2016 | Jun 30, 2016 | -9.9% | −1.8 |
| FY2015 | Jun 30, 2015 | -8.0% | −5.1 |
| FY2014 | Jun 30, 2014 | -2.9% | +7.8 |
| FY2013 | Jun 30, 2013 | -10.7% | +0.8 |
| FY2012 | Jun 30, 2012 | -11.5% | +7.5 |
| FY2011 | Jun 30, 2011 | -19.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | 14.7% | +29.2 |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -16.1% | −24.0 |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | 2.7% | −5.2 |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -7.6% | −6.6 |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -14.5% | −18.4 |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | 7.9% | +13.8 |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | 7.9% | +10.4 |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -1.0% | −0.4 |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | 4.0% | −2.6 |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -5.8% | −23.0 |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -2.5% | −2.5 |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -0.5% | +11.6 |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | 6.5% | +4.6 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | 17.2% | +29.2 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | 0.0% | +1.8 |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -12.1% | −5.2 |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | 1.9% | −4.7 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -12.1% | −6.4 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -1.8% | −5.4 |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -6.9% | +1.0 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | 6.6% | +29.6 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -5.7% | −0.2 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | 3.6% | +28.1 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -7.9% | −2.1 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -23.1% | −22.8 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -5.4% | −6.3 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -24.6% | −15.2 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -5.8% | −3.9 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -0.2% | −3.1 |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | 0.8% | +4.3 |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -9.4% | −16.6 |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -1.9% | −0.9 |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 2.9% | +7.2 |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -3.5% | −0.9 |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 7.2% | +8.6 |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -1.0% | +15.5 |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -4.3% | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -2.6% | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -1.3% | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -16.5% | – |
See a number that looks wrong?